FORFARMERS NV (FFARM.AS) Stock Fundamental Analysis
AMS:FFARM - Euronext Amsterdam - NL0011832811 - Common Stock - Currency: EUR
Overall FFARM gets a fundamental rating of 6 out of 10. We evaluated FFARM against 59 industry peers in the Food Products industry. FFARM has only an average score on both its financial health and profitability. FFARM is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, FFARM could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
FFARM had positive earnings in the past year.
FFARM had a positive operating cash flow in the past year.
FFARM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years FFARM had a positive operating cash flow.
1.2 Ratios
The Return On Assets of FFARM (3.33%) is comparable to the rest of the industry.
With a decent Return On Equity value of 9.56%, FFARM is doing good in the industry, outperforming 61.02% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.90%, FFARM is in the better half of the industry, outperforming 77.97% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FFARM is in line with the industry average of 6.44%.
The last Return On Invested Capital (7.90%) for FFARM is above the 3 year average (4.52%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.33% | ||
| ROE | 9.56% | ||
| ROIC | 7.9% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
1.3 Margins
FFARM has a worse Profit Margin (1.14%) than 64.41% of its industry peers.
FFARM's Profit Margin has improved in the last couple of years.
FFARM has a Operating Margin of 2.02%. This is in the lower half of the industry: FFARM underperforms 66.10% of its industry peers.
FFARM's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 18.88%, FFARM is not doing good in the industry: 77.97% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of FFARM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.02% | ||
| PM (TTM) | 1.14% | ||
| GM | 18.88% |
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FFARM is still creating some value.
The number of shares outstanding for FFARM remains at a similar level compared to 1 year ago.
The number of shares outstanding for FFARM has been reduced compared to 5 years ago.
FFARM has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.81 indicates that FFARM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.81, FFARM belongs to the top of the industry, outperforming 93.22% of the companies in the same industry.
FFARM has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as FFARM would need 3.80 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.80, FFARM is in the better half of the industry, outperforming 79.66% of the companies in the same industry.
FFARM has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
FFARM's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. FFARM outperforms 64.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 3.81 |
ROIC/WACC1.19
WACC6.64%
2.3 Liquidity
A Current Ratio of 1.11 indicates that FFARM should not have too much problems paying its short term obligations.
FFARM has a Current ratio of 1.11. This is in the lower half of the industry: FFARM underperforms 71.19% of its industry peers.
FFARM has a Quick Ratio of 1.11. This is a bad value and indicates that FFARM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.82, FFARM perfoms like the industry average, outperforming 45.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
FFARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4895.65%, which is quite impressive.
The Earnings Per Share has been growing by 14.71% on average over the past years. This is quite good.
FFARM shows a decrease in Revenue. In the last year, the revenue decreased by -7.70%.
FFARM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.20% yearly.
EPS 1Y (TTM)4895.65%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%83.47%
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%1.62%
3.2 Future
Based on estimates for the next years, FFARM will show a very strong growth in Earnings Per Share. The EPS will grow by 32.03% on average per year.
Based on estimates for the next years, FFARM will show a small growth in Revenue. The Revenue will grow by 5.29% on average per year.
EPS Next Y70.55%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue Next Year6.99%
Revenue Next 2Y4.44%
Revenue Next 3Y5.29%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.77, the valuation of FFARM can be described as correct.
Based on the Price/Earnings ratio, FFARM is valued a bit cheaper than the industry average as 69.49% of the companies are valued more expensively.
FFARM is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
FFARM is valuated reasonably with a Price/Forward Earnings ratio of 9.86.
Based on the Price/Forward Earnings ratio, FFARM is valued a bit cheaper than the industry average as 74.58% of the companies are valued more expensively.
FFARM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.15.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.77 | ||
| Fwd PE | 9.86 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, FFARM is valued cheaply inside the industry as 86.44% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FFARM indicates a rather cheap valuation: FFARM is cheaper than 83.05% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.96 | ||
| EV/EBITDA | 4.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FFARM's earnings are expected to grow with 32.03% in the coming years.
PEG (NY)0.18
PEG (5Y)0.87
EPS Next 2Y33.7%
EPS Next 3Y32.03%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.65%, FFARM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.21, FFARM pays a better dividend. On top of this FFARM pays more dividend than 84.75% of the companies listed in the same industry.
FFARM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.65% |
5.2 History
The dividend of FFARM decreases each year by -12.97%.
Dividend Growth(5Y)-12.97%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
FFARM pays out 41.40% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP41.4%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
AMS:FFARM (5/30/2025, 7:00:00 PM)
4.215
0 (-0.12%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners5.54%
Inst Owner ChangeN/A
Ins Owners5.49%
Ins Owner ChangeN/A
Market Cap376.32M
Analysts42.5
Price Target4.28 (1.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.65% |
Yearly Dividend0.15
Dividend Growth(5Y)-12.97%
DP41.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)27.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.77 | ||
| Fwd PE | 9.86 | ||
| P/S | 0.14 | ||
| P/FCF | 8.96 | ||
| P/OCF | 5.36 | ||
| P/B | 1.15 | ||
| P/tB | 1.8 | ||
| EV/EBITDA | 4.31 |
EPS(TTM)0.33
EY7.83%
EPS(NY)0.43
Fwd EY10.14%
FCF(TTM)0.47
FCFY11.16%
OCF(TTM)0.79
OCFY18.65%
SpS30.75
BVpS3.68
TBVpS2.34
PEG (NY)0.18
PEG (5Y)0.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.33% | ||
| ROE | 9.56% | ||
| ROCE | 10.29% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.67% | ||
| ROICexgc | 11.28% | ||
| OM | 2.02% | ||
| PM (TTM) | 1.14% | ||
| GM | 18.88% | ||
| FCFM | 1.53% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
ROICexc(3y)5.02%
ROICexc(5y)6.01%
ROICexgc(3y)6.45%
ROICexgc(5y)7.81%
ROCE(3y)5.89%
ROCE(5y)6.6%
ROICexcg growth 3Y23.14%
ROICexcg growth 5Y0.01%
ROICexc growth 3Y22.42%
ROICexc growth 5Y1.04%
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
F-Score6
Asset Turnover2.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 1.39 | ||
| Cap/Depr | 55.29% | ||
| Cap/Sales | 1.03% | ||
| Interest Coverage | 8.27 | ||
| Cash Conversion | 65.98% | ||
| Profit Quality | 133.76% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.81 |
F-Score6
WACC6.64%
ROIC/WACC1.19
Cap/Depr(3y)70.12%
Cap/Depr(5y)76.46%
Cap/Sales(3y)1.08%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4895.65%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%83.47%
EPS Next Y70.55%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%1.62%
Revenue Next Year6.99%
Revenue Next 2Y4.44%
Revenue Next 3Y5.29%
Revenue Next 5YN/A
EBIT growth 1Y201.09%
EBIT growth 3Y24.06%
EBIT growth 5Y0.93%
EBIT Next Year188.1%
EBIT Next 3Y50.85%
EBIT Next 5YN/A
FCF growth 1Y-19.39%
FCF growth 3Y40.78%
FCF growth 5Y-6.65%
OCF growth 1Y-18.84%
OCF growth 3Y8.69%
OCF growth 5Y-6.1%